6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile CAS 356783-31-8 Nadiifinta ≥98.0% (HPLC) Favipiravir Dhexdhexaad COVID-19
Soo-saare leh Nadiif Sarreysa iyo Tayo Deggan
Sahayda Ganacsi ee Favipiravir iyo Dhexdhexaadiyayaasha la xidhiidha:
Favipiravir CAS 259793-96-9
2-Aminopropanediamide CAS 62009-47-6
Diethyl Aminomalonate Hydrochloride CAS 13433-00-6
3,6-Dichloropyrazine-2-Carbonitrile CAS 356783-16-9
3,6-Difluoropyrazine-2-Carbonitrile CAS 356783-28-3
6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile CAS 356783-31-8
6-Bromo-3-Hydroxypyrazine-2-Carboxamide CAS 259793-88-9
3-Hydroxypyrazine-2-Carboxamide CAS 55321-99-8
Magaca Kiimikada | 6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile |
La mid ah | 6-Fluoro-3-oxo-3,4-Dihydropyrazine-2-Carbonitrile |
Lambarka CAS | 356783-31-8 |
Lambarka CAT | RF-API294 |
Heerka Saamiyada | Kaydka, Miisaanka Wax-soo-saarka Ilaa boqollaal Kiilogaram |
Qaanuunka molecular | C5H2FN3O |
Miisaanka Molecular | 139.09 |
Summada | Kiimikada Ruifu |
Shayga | Tilmaamaha |
Muuqashada | Jaalle cirro leh iyo budo caddaan ah |
Aqoonsiga | IR, HPLC |
Qoyaanka (KF) | ≤1.0% |
Hadhaaga dabka | ≤0.50% |
Xumaanta Keliya | ≤1.0% |
Wadarta wasakhda | ≤2.0% |
Biraha culus | ≤20pm |
daahirnimo | ≥98.0% (waxaa qoray HPLC) |
Heerka Imtixaanka | Heerka Ganacsiga |
Isticmaalka | Dhexdhexaadiyaha Favipiravir (CAS 259793-96-9);Ka-hortagga fayraska;COVID 19 |
Xidhmada: Dhalo, boorsada aluminium aluminium, durbaanka kartoonada, 25kg/Drum, ama sida waafaqsan shuruudaha macmiilka.
Xaaladda Kaydinta:Ku kaydi weelasha xiran meel qabow oo qallalan;Ka ilaali iftiinka, qoyaanka iyo cayayaanka.
6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile (CAS 356783-31-8) waa dhexdhexaadiye Favipiravir (CAS 259793-96-9).Favipiravir waa daawo cusub oo ka hortag fayrus ah oo ballaaran oo lagu beegsanayo RNA polymerase (RdRp) ku tiirsan RNA.Favipiravir waxaa asal ahaan soo saartay dabayaaqadii 1990-meeyadii shirkad ay markii dambe iibsatay shirkadda Japan ee Fujifilm taasoo qayb ka ahayd ka gudubka ganacsiga sawirka una gudubtay daryeelka caafimaadka.Ka dib markii lagu tijaabiyey noocyo kala duwan oo fayras ah, dawada waxaa laga ansixiyay Japan 2014 si loogu isticmaalo degdegga ah ee ka hortagga hargabka ama lagu daweeyo noocyada cusub ee hargabka.Intii lagu gudajiray faafitaanka coronavirus-ka cusub, natiijooyinka daraasadda bukaan-socodka ee Wajiga I ee daawada la daabacay Maarso 2020 waxay muujisay in daawadu ay yeelan karto saameynta dedejinta nadiifinta fayraska si loo yareeyo horumarka cudurka sambabada cusub ee coronavirus.Favipiravir waxa loo isticmaali karaa daawaynta bukaanada qaba COVID-19 ay WHO ku talisay.Waxaa caddeeyey Maamulaha Guud ee Dawooyinka ee Hindiya (DCGI) isticmaalka "xakamaynta degdega ah" ee bukaannada COVID-19.